title: Synthesis and biological evaluation of naloxone and naltrexone-derived hybrid opioids.
abstract: The synthesis and biological evaluation of hybrid opioids consisting of Naloxone or Naltrexone and a partial opioid peptide are described. These compounds were synthesized in a homogeneous solution as well as in solid phase. A hydrazone linkage was employed to connect the alkaloids to the tetrapeptides. In synthesizing the peptides some non-traditional methods, which provided excellent results, were explored. The solid phase synthesis was achieved by anchoring the Fmoc-Phe to the 2-chlorotrityl resin, followed by stepwise addition of two Fmoc-Gly units. Each addition step preceded by standard piperidine removal of the Fmoc from the prior amino acid (AA) residue. The final AA, Tyr, was added as its Boc derivative. The Boc-tetrapeptide was then separated from the resin with a TFE/AcOH/CH(2)Cl(2) mixture. In the solution synthesis, each peptide elongation step was accomplished by one-pot removal of the Fmoc from the prior AA residue and addition of the next Fmoc-AA. TBAF-thiol was used to cleanly remove the Fmoc, before adding the next Fmoc-AA in the presence of DIPEA and TBTU. All prepared hybrid ligands exhibited high affinities toward all three opioid receptors; moderate preferences for κ and μ receptors over δ receptor were observed. [(35)S]GTPγS binding assays indicated that these hybrid opioids are δ and μ antagonists but partial κ agonist.
authors.affiliation: Department of Chemistry, Indiana University Southeast, New Albany, IN 47150, USA. bnassim@ius.edu
authors.forename: Bahman E
authors.initials: BE
authors.lastname: Nassim
authors.forename: Ming-Lei
authors.initials: ML
authors.lastname: Wang
mesh_terms: D000595:Amino Acid Sequence; D000701:Analgesics, Opioid / Q000138:chemical synthesis / Q000737:chemistry / Q000494:pharmacology; D001665:Binding Sites; D020128:Inhibitory Concentration 50; D008855:Microscopy, Electron, Scanning; D008969:Molecular Sequence Data; D015394:Molecular Structure; D009270:Naloxone / Q000138:chemical synthesis* / Q000494:pharmacology*; D009271:Naltrexone / Q000138:chemical synthesis* / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000138:chemical synthesis / Q000494:pharmacology; D010455:Peptides / Q000737:chemistry / Q000235:genetics; D011485:Protein Binding / Q000187:drug effects; D011957:Receptors, Opioid / Q000737:chemistry; D060327:Solid-Phase Synthesis Techniques
chemical_list: D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D010455:Peptides; D011957:Receptors, Opioid; D009270:Naloxone; D009271:Naltrexone